Carissa Allen
Physician Assistant · Belmont, OHNPI 1346592268
Payments from drug & device makers
Across 197 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$689
- Novo Nordisk$445
- Merck$371
- Lilly USA, LLC$240
- AstraZeneca$222
- Boehringer Ingelheim$171
- plus $720 from 15 others
What the payments were for
- Food & beverage$2,850100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $689 |
| Novo Nordisk | 37 | $445 |
| Merck | 23 | $371 |
| Lilly USA, LLC | 16 | $240 |
| AstraZeneca | 15 | $222 |
| Boehringer Ingelheim | 12 | $171 |
| Amgen | 10 | $162 |
| Teva Pharmaceuticals USA, Inc. | 6 | $94 |
| Johnson & Johnson | 6 | $89 |
| GSK | 4 | $69 |
| Amarin Pharma, Inc. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Pfizer | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Bayer | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Organon | 1 | $13 |
How this compares
$2,858 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 34 | $42,513 |
| TrulicityDulaglutide | 42 | $36,924 |
| OzempicSemaglutide | 24 | $33,295 |
| FarxigaDapagliflozin Propanediol | 40 | $31,306 |
| MounjaroTirzepatide | 25 | $28,785 |
| EliquisApixaban | 29 | $23,730 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $8,964 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $6,997 |
| Gabapentin | 98 | $2,607 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,756 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,740 |
| Celecoxib | 33 | $1,184 |
| Omeprazole | 89 | $1,183 |
| Levothyroxine Sodium | 139 | $1,104 |
| Atorvastatin Calcium | 123 | $1,080 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $240 | $65,71067 claims |
| Boehringer IngelheimJardiance | $171 | $42,51334 claims |
| Novo NordiskOzempic | $445 | $33,29524 claims |
| AstraZenecaFarxiga | $222 | $31,30640 claims |
| PfizerEliquis | $47 | $23,73029 claims |
| GSKAnoro Ellipta | $69 | $8,96413 claims |
| AbbVieSynthroid | $689 | $53824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Belmont
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.